The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
Open accessAbstract
Objective To review outcomes in randomised controlled trials comparing hydralazine against other antihypertensives for severe hypertension in pregnancy. Study design Meta-analysis of randomised controlled trials (published between 1966 and September 2002) of short acting antihypertensives for severe hypertension in pregnancy. Independent data abstraction by two reviewers. Data were entered into RevMan software for analysis (fixed effects model, relative risk and 95% confidence interval); in a secondary analysis, risk difference was also calculated. Results Of 21 trials (893 women), eight compared hydralazine with nifedipine and five with labetalol. Hydralazine was associated with a trend towards less persistent severe hypertension than labetalol (relative risk 0.29 (95% confidence interval 0.08 to 1.04); two trials), but more severe hypertension than nifedipine or isradipine (1.41 (0.95 to 2.09); four trials); there was significant heterogeneity in outcome between trials and differences in methodological quality. Hydralazine was associated with more maternal hypotension (3.29 (1.50 to 7.23); 13 trials); more caesarean sections (1.30 (1.08 to 1.59); 14 trials); more placental abruption (4.17 (1.19 to 14.28); five trials); more maternal oliguria (4.00 (1.22 to 12.50); three trials); more adverse effects on fetal heart rate (2.04 (1.32 to 3.16); 12 trials); and more low Apgar scores at one minute (2.70 (1.27 to 5.88); three trials). For all but Apgar scores, analysis by risk difference showed heterogeneity between trials. Hydralazine was associated with more maternal side effects (1.50 (1.16 to 1.94); 12 trials) and with less neonatal bradycardia than labetalol (risk difference -0.24 (-0.42 to -0.06); three trials). Conclusions The results are not robust enough to guide clinical practice, but they do not support use of hydralazine as first line for treatment of severe hypertension in pregnancy. Adequately powered clinical trials are needed, with a comparison of labetalol and nifedipine showing the most promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107928 · Cited by 3,270
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
Liu, L., Wang, J. G., Gong, L., Liu, G., & Staessen, J. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816120-00016 · Cited by 730
Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-1993
Stationery Office (1996) · HMSO eBooks · Cited by 477
Drugs for treatment of very high blood pressure during pregnancy
Duley, L., Meher, S., & Jones, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001449.pub3 · Cited by 423
Management of hypertension in pregnancy
Magee, L. A., Ornstein, M. P., & von Dadelszen, P. (1999) · BMJ · doi:10.1136/bmj.318.7194.1332 · Cited by 322
Self-citationPrinciples of and Procedures for Systematic Reviews
Egger, M., & Smith, G. D. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch2 · Cited by 234
The detection, investigation and management of hypertension in pregnancy: executive summary
Brown, M., Hague, W., Higgins, J., Lowe, S., McCowan, L., Oats, J., Peek, M., Rowan, J., & Walters, B. (2000) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2000.tb01136.x · Cited by 197
Mabie, W., Gonzales, A. R., Sibai, B. M., & Amon, E. (1988) · Obstetric Anesthesia Digest · doi:10.1097/00132582-198804000-00039 · Cited by 168
Rey, É., LeLorier, J., Burgess, E. D., Lange, I. R., & Leduc, L. (1997) · Europe PMC (PubMed Central) · Cited by 165
Nifedipine in the treatment of severe preeclampsia.
Fenakel, K., Fenakel, G., Appelman, Z., Lurie, S. B., Katz, Z., & Shoham, Z. (1991) · PubMed · Cited by 163
Vermillion, S. T., Scardo, J. A., Newman, R., & Chauhan, S. P. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70314-5 · Cited by 150
Magnesium Plus nifedipine: Potentiation of hypotensive effect in preeclampsia?
Waisman, G. D., Mayorga, L. M., Cámera, M. I., Vignoio, C. A., & Martinotti, A. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80072-3 · Cited by 140
Mabie, W. C., González, A. R., Sibai, B., et al. (1988) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(88)90057-4 · Cited by 116
Calcium-Channel Blockers for Hypertension — Uncertainty Continues
Cutler, J. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381009 · Cited by 84
Intravenous Labetalol and Intravenous Dihydralazine in Severe Hypertension in Pregnancy
Garden, A., Davey, D. A., & Dommisse, J. (1982) · Clinical and Experimental Hypertension Part B Hypertension in Pregnancy · doi:10.3109/10641958209139860 · Cited by 65
Harper, A., & Murnaghan, G. A. (1991) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb10339.x · Cited by 60
Report on Confidential Enquiries into Maternal Deaths in England and Wales 1982-1984.
TURNBULL, A. C., Tindall, V. R., Rw, B., Robson, G., Dawson, I. M., Cloake, E. P., Js, A., & Botting, B. (1989) · PubMed · Cited by 56
Nifedipine in acute hypertensive emergencies in pregnancy.
Sj, S., Moodley, J., & Becker, P. J. (1989) · PubMed · Cited by 49
Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
Ashe, R. G., Moodley, J., Richards, M., & Rh, P. (1987) · PubMed · Cited by 46
Wacker, J., Werner, P., Walter‐Sack, I., & Bastert, G. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027825 · Cited by 43
Bolte, A. C., van Eyck, J., Kanhai, H. H. H., Bruinse, H. W., van Geijn, H. P., & Dekker, G. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70216-4 · Cited by 41
Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial.
Rossouw, H. J., Howarth, G. R., & Odendaal, H. J. (1995) · PubMed · Cited by 31
Martins-Costa, S., Ramos, J. G. L., Barros, E., Bruno, R. M., Costa, C. A. R., & Goldin, J. R. (1992) · Clinical and Experimental Hypertension Part B Hypertension in Pregnancy · doi:10.3109/10641959209031031 · Cited by 30
A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy
Moodley, J., & Gouws, E. (1992) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb13872.x · Cited by 26
Brown, M. A., McCowan, L. M. E., North, R. A., & Walters, B. N. J. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb123300.x · Cited by 26
Duggan, P., McCowan, L. M. E., & Stewart, A. W. (1992) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1992.tb02846.x · Cited by 23
Kincaid‐Smith, P. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121907.x · Cited by 9
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
Self-citation2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Metadata
- Authors
- Magee, L. A., Cham, C., Waterman, E. J., Ohlsson, A., & von Dadelszen, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2003-10-23
- Volume
- 327
- Issue
- 7421
- Pages
- 955
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2020451618
- Cited by
- 442
- References
- 30
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.